About: RVL Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, Argentina, and Hungary. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.00
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
RVLPQ NASDAQ RVL Pharmaceuticals plc
RVL Pharmaceuticals plc share price
RVLPQ price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
RVLPQ price performance
RVLPQ Market Signals